OLA Blog

ROX or RISK?!

Written by Meguid El Nahas on Tuesday, 30 June 2015. Posted in OLA Blog

ROX or RISK?!
Lancet. 2015 Apr 25;385(9978):1634-41. doi: 10.1016/S0140-6736(14)62053-5. Epub 2015 Jan 23. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled...

THE GLASSOCK BLOG: CKD EPIDEMIC...WHAT EPIDEMIC?

Written by Meguid El Nahas on Tuesday, 09 June 2015. Posted in OLA Blog

THE GLASSOCK BLOG: CKD EPIDEMIC...WHAT EPIDEMIC?
Is There a Real Global Epidemic of Chronic Kidney Disease? Numerous publications have asserted that the global prevalence of chronic kidney disease (CKD) in adults is generally between 10-13% (as determined from the KDOQI or KDIGO...

CKD "Epidemic": Wishful or Shameful Thinking?

Written by Meguid El Nahas on Monday, 08 June 2015. Posted in OLA Blog

CKD "Epidemic": Wishful or Shameful Thinking?
Prof Richard Glassock wrote in reference to the latest publication in the Lancet on the Global Burden of Disease Study 2013: (The Lancet On line 8th of June 2015) It represents massive data collection and a complicated analysis but the main...

SIMPLICITY3...NOT SO SIMPLE?

Written by Meguid El Nahas on Sunday, 07 June 2015. Posted in OLA Blog

SIMPLICITY3...NOT SO SIMPLE?
Blog based on a lecture by Professor Samir Mallat at the Global Kidney Academy Master Class held in Prague on 7 June 2015. SIMPLICITY HTN3 showed no effect of renal sympathetic denervation (RSD) on the control of hypertension. Subgroup analyses...

NEW AGE CALIBRATED CKD CLASSIFICATION 2015

Written by Meguid El Nahas on Tuesday, 02 June 2015. Posted in OLA Blog

NEW AGE CALIBRATED CKD CLASSIFICATION 2015
  Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List   A Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager   Format Summary...

Clinical Trials Update - ERA-EDTA

Written by arif khwaja on Friday, 29 May 2015. Posted in OLA Blog

Clinical Trials Update - ERA-EDTA
A quick update from the late clinical trials session from the ERA-EDTA which was a high quality session Jurgen Flöege presented data from the german STOP-IgA Nephropathy trial. Full details of the protocol can be found here but in...

High Serum Bicarbonate in CKD: Slows CKD and Increases Death!

Written by Meguid El Nahas on Thursday, 07 May 2015. Posted in OLA Blog

High Serum Bicarbonate in CKD: Slows CKD and Increases Death!
J Am Heart Assoc. 2015 Apr 20;4(4). pii: e001599. doi: 10.1161/JAHA.114.001599. Persistent High Serum Bicarbonate and the Risk of Heart Failure in Patients With Chronic Kidney Disease (CKD): A Report From the Chronic Renal Insufficiency...

THE PHOSPHORUS PYRAMID!

Written by Pierre Delanaye on Saturday, 25 April 2015. Posted in OLA Blog

THE PHOSPHORUS PYRAMID!
BLOG POSTED BY PROF PIERRE DELANAYE:   http://www.ncbi.nlm.nih.gov/pubmed/25603926   http://www.biomedcentral.com/1471-2369/16/9   BMC Nephrol. 2015 Jan 20;16:9. doi: 10.1186/1471-2369-16-9. The "phosphorus pyramid": a...

Conferences, Speakers and CNE...the Gap!

Written by Meguid El Nahas on Friday, 24 April 2015. Posted in OLA Blog

Conferences, Speakers and CNE...the Gap!
The Gap between Theoretical and Practical/Clinically relevant Nephrology Knowledge grows with the type of teaching and conferences given in emerging countries and elsewhere... Endless lectures...when the speaker shows off his/her knowledge and...

Genotyping allografts: Dream or Reality?

Written by Meguid El Nahas on Saturday, 18 April 2015. Posted in OLA Blog

Genotyping allografts: Dream or Reality?
Growing evidence is implicating a genetic absis for CKD in African-Americans linked to mutations in the APOL1 gene. A genetic mutation that served sub-saharan Africans well some 10,000 years ago as it confered trypanolytic activity against...